Robert N. Wilson
CIK: 0001189022
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CalciMedica, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Oct 1, 2026CALC
CalciMedica, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
20K shares- - Aug 19, 2026CALC
CalciMedica, Inc.
Award(A)DirectWarrant
1.2M shares- - Aug 19, 2026CALC
CalciMedica, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
10K shares- - Aug 19, 2026CALC
CalciMedica, Inc.
Award(A)DirectWarrant
1.2M shares- - Jun 25, 2026CALC
CalciMedica, Inc.
Award(A)Direct1.2M shares at avg. $0.80$950K - Jul 18, 2025CALC
CalciMedica, Inc.
Purchase(P)Direct4.5K shares at avg. $2.87$13K - Jun 24, 2025CALC
CalciMedica, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
10K shares- - Jun 24, 2025CALC
CalciMedica, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
12K shares- - Jun 24, 2025CALC
CalciMedica, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
36.6K shares- - Jun 24, 2025CALC
CalciMedica, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
10K shares- - Nov 1, 2024CALC
CalciMedica, Inc.
Purchase(P)Direct53.3K shares at avg. $3.75$200K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | CALC CalciMedica, Inc. | Award(A) Director Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| Aug 19, 2026 | CALC CalciMedica, Inc. | Award(A) Warrant | 1,182,621 | - | - | Direct |
| Aug 19, 2026 | CALC CalciMedica, Inc. | Award(A) Director Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| Aug 19, 2026 | CALC CalciMedica, Inc. | Award(A) Warrant | 1,182,621 | - | - | Direct |
| Jun 25, 2026 | CALC CalciMedica, Inc. | Award(A) | 1,182,621 | $0.80 | $949,999 | Direct |
| Jul 18, 2025 | CALC CalciMedica, Inc. | Purchase(P) | 4,500 | $2.87 | $12,915 | Direct |
| Jun 24, 2025 | CALC CalciMedica, Inc. | Award(A) Director Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| Jun 24, 2025 | CALC CalciMedica, Inc. | Award(A) Director Stock Option (Right to Buy) | 12,031 | - | - | Direct |
| Jun 24, 2025 | CALC CalciMedica, Inc. | Award(A) Director Stock Option (Right to Buy) | 36,562 | - | - | Direct |
| Jun 24, 2025 | CALC CalciMedica, Inc. | Award(A) Director Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| Nov 1, 2024 | CALC CalciMedica, Inc. | Purchase(P) | 53,333 | $3.75 | $199,999 | Direct |
1-11 of 11 transactions
About WILSON ROBERT N
WILSON ROBERT N (SEC CIK 0001189022) files insider reports with the SEC as Director of CalciMedica, Inc. (CALC).
Signal8 holds 6 ownership filings by WILSON ROBERT N, all Form 4s, filed between Nov 1, 2024 and Oct 5, 2026. Those filings report 11 transactions, from Nov 1, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on WILSON ROBERT N's filings is in LA JOLLA, CA.
Recent filings by WILSON ROBERT N
- Oct 1, 2026: Grant or award of CALC derivative securities (Form 4, code A).
- Aug 19, 2026: Grants or awards of CALC derivative securities (3 lines, Form 4, code A).
- Jun 25, 2026: Grant or award of CALC shares (Form 4, code A).
- Jul 18, 2025: Open-market purchase of CALC shares (Form 4, code P).
- Jun 24, 2025: Grants or awards of CALC derivative securities (4 lines, Form 4, code A).
Other insiders filing for CalciMedica, Inc. (CALC)
- Glicklich Alan, Director
- Zaytsev Evgeny, Director
- Guerard Frederic, Director
- Shaw Allan, Director
- Hebbar Sudarshan, Chief Medical Officer
- Stauderman Kenneth A., Chief Scientific Officer